Breast cancer remains the number one diagnosed cancer in women in the United States, other than skin cancer, according to the ...
Cancer incidence continues to rise for many common cancers—especially for women. The incidence rate for women younger than 50 ...
The US regulator has cleared TROP2-directed ADC datopotamab deruxtecan (Dato-DXd) under the Datroway trade name as a ...
Breast Cancer Now said olaparib will be an ‘valuable alternative’ for patients with a certain type of secondary breast cancer ...
"During Joe Rogan’s podcast on Jan. 9, Mel Gibson promoted drugs that are not scientifically proven cancer treatments," the ...
DATROWAY® (datopotamab deruxtecan-dlnk) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-negative (IHC 0, IHC 1+ or ...
Several major drugmakers have restricted commercially insured patients from their patient assistance programs, leaving ...
Dr. Liz O'Riordan wants people to know that there is no "magic fix" and no special diet that will cure cancer, despite many of the online claims out there.
DATROWAY Approved in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer ...
The Breast Reconstruction Market has witnessed remarkable advancements in recent years, driven by medical innovations, a ...
Bengaluru: For Latha (name changed), a 37-year-old woman diagnosed with breast cancer in April 2024, the news of her illness ...
Alarming rates of secondary breast cancer are on the rise, with the figure increasing year on year since 2018 so it's more important than ever to know where it is most likely to occur and what to look ...